ALSO NOTED: Critical Therapeutics shares surge; Orchid gets FDA OK; MedImmune pulls flyer; and much more...

> Shares of Critical Therapeutics got a boost today after the biotech announced a manufacturing deal for its asthma drug Zyflo, bringing it one step closer to its reintroduction to the market. Article

> India's Orchid Chemicals has received FDA approval of its ANDA for cephalexin capsules. Story

> MedImmune has pulled a flyer for FluMist after the FDA complained it contained misleading information. Story

> Auxilium Pharmaceuticals of Malvern, Pennsylvania, has raised $40.4 million in a private placement. Release

> Conforma has licensed an anti-cancer drug from Sumitomo Pharmaceuticals. Story

> Schering-Plough says its once-daily dose of Nasonex is safe and effective. Story

> Just weeks after a Supreme Court decision giving federal officials a green ligh to prosecute people for the use of medical marijuana, the Rhode Island legislature passed a bill allowing its use. Article

> Italy's Bioindustry Park Canavese announced six new biotechs in its Bioincubator. Release

And Finally... State workers in Georgia will soon face $100 co-pays for some branded drugs as employers continue to shift costs of ever-rising pharmaceuticals. Story

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.